Teva Pharmaceutical Industries (TEVA) EPS (Weighted Average and Diluted) Growth (5y) (2021 - 2026)
Teva Pharmaceutical Industries (TEVA) EPS (Weighted Average and Diluted) Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.52 Bn | 35.79 Bn | 1.97 Bn |
| 2 | Zoetis | 33.53 Bn | 31.59 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.92 Bn | 21.77 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.96 Bn | 16.88 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.47 Bn | 15.15 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.76 Bn | 11.33 Bn | 785.00 Mn |
| 7 | Alkermes | 7.11 Bn | 6.60 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.53 Bn | 6.03 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 5.98 Bn | 5.23 Bn | 396.79 Mn |
| 10 | Liquidia | 5.44 Bn | 5.22 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.66% |
| Dec 31, 2025 | 23.97% |
| Sep 30, 2025 | 15.92% |
| Jun 30, 2025 | 13.05% |
| Mar 31, 2025 | 24.57% |
| Dec 31, 2024 | -31.28% |
| Sep 30, 2024 | -6.10% |
| Jun 30, 2024 | -3.55% |
| Mar 31, 2024 | -3.71% |
| Dec 31, 2023 | 16.48% |
| Sep 30, 2023 | 17.32% |
| Jun 30, 2023 | -26.58% |
| Mar 31, 2023 | -17.02% |
| Dec 31, 2022 | 36.59% |
| Sep 30, 2022 | -37.40% |
| Jun 30, 2022 | 47.81% |
| Mar 31, 2022 | -28.54% |
| Dec 31, 2021 | 32.78% |